Redhill Biopharma Ltd. ADR [NASDAQ: RDHL] gained 97.87% or 0.38 points to close at $0.76 with a heavy trading volume of 358087739 shares.
The daily chart for RDHL points out that the company has recorded 31.03% gains over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 276.88K shares, RDHL reached to a volume of 358087739 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Redhill Biopharma Ltd. ADR [RDHL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RDHL shares is $40.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RDHL stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Redhill Biopharma Ltd. ADR shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 31, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on May 18, 2021, representing the official price target for Redhill Biopharma Ltd. ADR stock.
The Average True Range (ATR) for Redhill Biopharma Ltd. ADR is set at 0.05, with the Price to Sales ratio for RDHL stock in the period of the last 12 months amounting to 0.68. The Price to Book ratio for the last quarter was 0.86, with the Price to Cash per share for the same quarter was set at 0.51.
Trading performance analysis for RDHL stock
Redhill Biopharma Ltd. ADR [RDHL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 100.00. With this latest performance, RDHL shares gained by 109.94% in over the last four-week period, additionally plugging by 31.03% over the last 6 months – not to mention a drop of -39.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RDHL stock in for the last two-week period is set at 86.49, with the RSI for the last a single of trading hit 90.93, and the three-weeks RSI is set at 81.74 for Redhill Biopharma Ltd. ADR [RDHL]. The present Moving Average for the last 50 days of trading for this stock 0.4088, while it was recorded at 0.4641 for the last single week of trading, and 0.6406 for the last 200 days.
Redhill Biopharma Ltd. ADR [RDHL]: A deeper dive into fundamental analysis
Redhill Biopharma Ltd. ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.78 and a Current Ratio set at 0.96.
An analysis of Institutional ownership at Redhill Biopharma Ltd. ADR [RDHL]
The top three institutional holders of RDHL stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in RDHL stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in RDHL stock with ownership which is approximately 5.1238%.
